Cohance Lifesciences Limited
COHANCE
Rank in Stocks
#6386
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Share Price
$5.05
Last synced: 2026-10-19
Market Cap
$1.93B
Change (1 day)
-1.44%
Change (1 year)
-57.38%
Country
IN
Trade Cohance Lifesciences Limited (COHANCE)
Category
Healthcare
P/B ratio for Cohance Lifesciences Limited (COHANCE)
P/B ratio as of October 2026 TTM: 22.54
According to Cohance Lifesciences Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 22.54. At the end of 2024 the company had a P/B ratio of 8.31.
P/B ratio history for Cohance Lifesciences Limited from 2019 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 22.54 | 41.50% |
| 2025 | 15.93 | 91.72% |
| 2024 | 8.31 | 19.91% |
| 2023 | 6.93 | -32.77% |
| 2022 | 10.31 | -3.75% |
| 2021 | 10.71 | 253.56% |
| 2020 | 3.03 | -58.32% |
| 2019 | 7.27 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -77.64% |
IN
|
